82-OR: Effect of Semaglutide 2.4 mg on Glucose Metabolism and Body Weight in Adults with Overweight/Obesity and Type 2 Diabetes in the STEP 2 Trial

82-OR: Effect of Semaglutide 2.4 mg on Glucose Metabolism and Body Weight in Adults with Overweight/Obesity and Type 2 Diabetes in the STEP 2 Trial

The STEP 2 trial showed mean weight loss of 9.6% with semaglutide 2.4 mg vs. 7.0% with semaglutide 1.0 mg vs. 3.4% with placebo (PBO; both p

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2021-06, Vol.70 (Supplement_1)
Hauptverfasser: PERREAULT, LEIGH, DAVIES, MELANIE J., FÆRCH, LOUISE, JEPPESEN, OLE, PAKSERESHT, ARASH, PEDERSEN, SUE, ROSENSTOCK, JULIO, SHIMOMURA, IICHIRO, VILJOEN, ADIE, WADDEN, THOMAS A., LINGVAY, ILDIKO
Format: Artikel
Sprache:eng
Schlagworte:
Antidiabetics
Beta cells
Body weight
Body weight loss
Diabetes
Diabetes mellitus (non-insulin dependent)
Glucose
Glucose metabolism
Insulin
Insulin resistance
Metabolism
Obesity
Overweight
Placebos
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The STEP 2 trial showed mean weight loss of 9.6% with semaglutide 2.4 mg vs. 7.0% with semaglutide 1.0 mg vs. 3.4% with placebo (PBO; both p
ISSN:0012-1797
1939-327X
DOI:10.2337/db21-82-OR